Brent Egan to Ischemic Attack, Transient
This is a "connection" page, showing publications Brent Egan has written about Ischemic Attack, Transient.
Connection Strength
0.533
-
Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke. J Neurol Sci. 2022 10 15; 441:120334.
Score: 0.184
-
Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes. J Neurol Sci. 2017 Apr 15; 375:404-410.
Score: 0.127
-
Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. J Neurol. 2014 Jul; 261(7):1405-12.
Score: 0.104
-
Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. J Neurol. 2013 Feb; 260(2):590-6.
Score: 0.094
-
Increased platelet activation in early symptomatic vs. asymptomatic carotid stenosis and relationship with microembolic status: results from the Platelets and Carotid Stenosis Study. J Thromb Haemost. 2013 Jul; 11(7):1407-16.
Score: 0.025